Document is current

Any future updates will be listed below

Eculizumab for the treatment of atypical hemolytic uremic syndrome recurrence after kidney transplantation associated with complement factor H mutations: a case report with a 5-year follow-up

Crossref DOI link: https://doi.org/10.1007/s11255-016-1234-y

Published Online: 2016-02-10

Published Print: 2016-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark